IGF2BP2 and urinary bladder carcinoma: Additionally, developing safe and effective interventions targeting the LUCAT1/IGF2BP2/HMGA1 signaling axis to effectively inhibit the stemness transformation of bladder cancer cells and suppress chemotherapy resistance warrants further investigation.